BINDING AFFINITY PREDICTION OF DRUG CANDIDATES THAT POTENTIALLY BECOME MPRO SARS-COV-2 INHIBITORS USING RANDOM FOREST REGRESSION
The coronavirus (COVID-19) was first discovered in December 2019 in Wuhan, Hubei Province, China. This disease has spread to all countries in the world causing millions of deaths. Therefore, currently there are a lot of studies researching for a drug to cure COVID-19. One of the computational drug d...
Saved in:
Main Author: | Restreva Danestiara, Venia |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/54824 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
Phylogenetic network analysis of SARS-CoV-2 Mpro protease and the in silico screening of bioactive compounds from Philippine medicinal plants as potential Mpro inhibitors
by: Villanueva, Jose Antonio B.
Published: (2021) -
Zingiber officinale: Ayurvedic Uses of the Plant and In Silico Binding Studies of Selected Phytochemicals With Mpro of SARS-CoV-2
by: Rownak Jahan, et al.
Published: (2022) -
SYNTHESIS OF 6-AMINOPENICILLANIC ACID DERIVATIVES AND MOLECULAR DOCKING STUDY AS SARS-COV-2 MAIN PROTEASE (MPRO) INHIBITORS
by: Dwiputri Aminah, Agniya -
SARS-CoV-2 Mpro inhibitor identification using a cellular gain-of-signal assay for high-throughput screening
by: Delgado, Renee, et al.
Published: (2024) -
AMIDATION REACTION OF 6-AMINOPENICILLANIC ACID AND CYCLIC ANHYDRIDE AND IN SILICO STUDY OF ITS POTENTIAL AS INHIBITOR OF MPRO SARS-COV-2
by: Kofa, Rakatian